You are viewing the site in preview mode

Skip to main content

Table 1 Double-Blind Placebo-Controlled Studies of Local Nasal Immunotherapy

From: Local Nasal Specific Immunotherapy for Allergic Rhinitis

Author, Year Age Range (yrs) No of Patients (Active/Placebo) Allergen Duration Type of Extract
Johansson, 1979 [13] Ad 12/11 Grass 14 wk Aqueous, modified
Nickelsen, 1981 [14] 16-66 38/34 Ragweed 3 mo Aqueous, modified
Welsh, 1981 [15] 13-58 18/15 Ragweed 20 wk Aqueous
Schumacher, 1982 [16] 20-53 8/7 Grass 10 wk Powder, modified
Georgitis, 1983 [17] 16-67 31/13 Grass 10 wk Aqueous, modified
Georgitis, 1984 [18] Ad 29/16 Grass 10 wk Aqueous, modified
Andri, 1992 [19] 14-54 8/8 Parietaria 18 wk Powder, modified
Andri, 1993 [20] 15-54 11/10 Mite 12 mo Powder
Passalacqua, 1995 [21] 20-56 9/9 Parietaria 5 mo Powder
D'Amato, 1995 [22] 13-37 10/10 Parietaria 8 mo Powder
Andri, 1995 [23] 17-56 14/14 Birch 22 wk Powder
Fanales-Belasio, 1995 [24] 16-49 10/10 Mite 3 mo Aqueous
Andri, 1996 [25] 14-52 13/15 Grass 4 mo Powder
Cirla, 1996 [26] 17-44 11/11 Birch/alder 4 mo Powder
Bardare, 1996 [27] 5-15 19/20 Grass 3 mo Powder
Gaglani, 1997 [28] 18-35 13/14 Weed mix 4 mo Aqueous
Bertoni, 1999 [29] 18-43 10/10 Grass 3 mo Aqueous
Motta, 2000 [30] 13-55 55/47 Grass/mite 8 mo Aqueous
Pocobelli, 2001 [31] 16-45 22/21 Grass 4 mo Powder, modified
Marcucci, 2002 [32] 4-15 16/16 Mite 18 mo Powder, modified
Passali, 2002 [33] 16-47 18/18 Mite 8 mo Powder, modified
  1. Ad = advanced age; wk = weeks.